Beacon Harbor Wealth Advisors, Inc. Amgen Inc Transaction History

Beacon Harbor Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $232,687 - $262,498	-910 Reduced 6.55%	12,993 $3.74 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.82 Million - $2.27 Million	-8,345 Reduced 37.51%	13,903 $3.74 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $263,980 - $312,151	1,232 Added 5.86%	22,248 $4.94 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $38,384 - $46,784	-170 Reduced 0.8%	21,016 $5.08 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $690,296 - $877,104	-3,014 Reduced 12.45%	21,186 $5.56 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $55,370 - $61,617	-240 Reduced 0.98%	24,200 $5.89 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $5.36 Million - $5.93 Million	24,440 New	24,440 $5.91 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Beacon Harbor Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Harbor Wealth Advisors, Inc. with notifications on news.